Literature DB >> 34757219

Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes Registry.

Rachel Cusatis1, Kathryn E Flynn2, Sumithira Vasu3, Joseph Pidala4, Lori Muffly5, Joseph Uberti6, Roni Tamari7, Deborah Mattila8, Alisha Mussetter8, Ruta Bruzauskas9, Min Chen2, Erin Leckrone10, Judith Myers2, Lih-Wen Mau10, J Douglas Rizzo2, Wael Saber2, Mary Horowitz2, Stephanie J Lee11, Linda J Burns12, Bronwen Shaw2.   

Abstract

The importance of patient-reported outcomes (PROs) in cellular therapies, including hematopoietic cell transplantation (HCT) is highlighted in this study. Longitudinal collection of PROs in a registry is recommended for several reasons, yet to date, PROs are not routinely collected from HCT patients to augment clinical registry data. The aim of this study was to determine the feasibility of electronic PRO data collection by a national clinical outcomes registry, by assessing differences between who does and does not report PROs. We conducted a cross-sectional pilot collection of PROs from HCT recipients after treatment using computer-adapted tests from the Patient-Reported Outcome Measurement Information System (PROMIS). We implemented centralized data collection through the Center for International Blood and Marrow Transplant Research (CIBMTR) among patients who underwent HCT for myelodysplastic syndromes (MDS), were at least 6 months post-HCT, and spoke English or Spanish. The main objective was identifying patient, disease, and transplant-related differences associated with completion of electronic PROs. Patients were excluded from analysis if they were determined to be ineligible (deceased, did not speak English or Spanish, refused to be contacted by the CIBMTR). A total of 163 patients were contacted and potentially eligible to participate; of these, 92 (56%) enrolled and 89 (55%) completed the PRO assessment. The most frequent reason for incomplete surveys was inability to contact patients (n = 88), followed by declining to participate in the study (n = 37). There were no sociodemographic or age differences between those who completed the PRO survey (n = 89) and eligible nonresponders (n = 155). Patient scores were within 3 points of the US average of 50 for all symptoms and functioning except physical functioning. Responders and nonresponders did not exhibit meaningfully different sociodemographic characteristics. Difficulty contacting patients posed the greatest barrier and also provided the greatest opportunity for improvement. Once enrolled, survey completion was high. These results support standardizing centralized PRO data collection through the CIBMTR registry.
Copyright © 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cellular therapy; Clinical outcomes registry; Hematopoietic cell transplantation; Patient-Reported Outcome Measurement Information System (PROMIS); Patient-reported outcomes

Mesh:

Year:  2021        PMID: 34757219      PMCID: PMC8915447          DOI: 10.1016/j.jtct.2021.10.016

Source DB:  PubMed          Journal:  Transplant Cell Ther        ISSN: 2666-6367


  27 in total

1.  How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMIS fatigue item bank example.

Authors:  Jin-Shei Lai; David Cella; Seung Choi; Doerte U Junghaenel; Christopher Christodoulou; Richard Gershon; Arthur Stone
Journal:  Arch Phys Med Rehabil       Date:  2011-10       Impact factor: 3.966

2.  Evaluation of a preliminary physical function item bank supported the expected advantages of the Patient-Reported Outcomes Measurement Information System (PROMIS).

Authors:  M Rose; J B Bjorner; J Becker; J F Fries; J E Ware
Journal:  J Clin Epidemiol       Date:  2008-01       Impact factor: 6.437

3.  Development, feasibility and compliance of a web-based system for very frequent QOL and symptom home self-assessment after hematopoietic stem cell transplantation.

Authors:  N Bush; G Donaldson; C Moinpour; M Haberman; D Milliken; V Markle; J Lauson
Journal:  Qual Life Res       Date:  2005-02       Impact factor: 4.147

4.  Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS®): depression, anxiety, and anger.

Authors:  Paul A Pilkonis; Seung W Choi; Steven P Reise; Angela M Stover; William T Riley; David Cella
Journal:  Assessment       Date:  2011-06-21

5.  Development and validation of patient-reported outcome measures for sleep disturbance and sleep-related impairments.

Authors:  Daniel J Buysse; Lan Yu; Douglas E Moul; Anne Germain; Angela Stover; Nathan E Dodds; Kelly L Johnston; Melissa A Shablesky-Cade; Paul A Pilkonis
Journal:  Sleep       Date:  2010-06       Impact factor: 5.849

6.  Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation.

Authors:  William A Wood; Allison M Deal; Amy Abernethy; Ethan Basch; Claudio Battaglini; Yoon Hie Kim; Julia Whitley; Charlotte Shatten; Jon Serody; Thomas Shea; Bryce B Reeve
Journal:  Biol Blood Marrow Transplant       Date:  2012-12-16       Impact factor: 5.742

7.  Peripheral-blood stem cells versus bone marrow from unrelated donors.

Authors:  Claudio Anasetti; Brent R Logan; Stephanie J Lee; Edmund K Waller; Daniel J Weisdorf; John R Wingard; Corey S Cutler; Peter Westervelt; Ann Woolfrey; Stephen Couban; Gerhard Ehninger; Laura Johnston; Richard T Maziarz; Michael A Pulsipher; David L Porter; Shin Mineishi; John M McCarty; Shakila P Khan; Paolo Anderlini; William I Bensinger; Susan F Leitman; Scott D Rowley; Christopher Bredeson; Shelly L Carter; Mary M Horowitz; Dennis L Confer
Journal:  N Engl J Med       Date:  2012-10-18       Impact factor: 91.245

8.  PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors.

Authors:  Bronwen E Shaw; Karen L Syrjala; Lynn E Onstad; Eric J Chow; Mary E Flowers; Heather Jim; K Scott Baker; Sarah Buckley; Diane L Fairclough; Mary M Horowitz; Stephanie J Lee
Journal:  Cancer       Date:  2017-10-26       Impact factor: 6.860

Review 9.  Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention.

Authors:  Joseph Pidala; Claudio Anasetti; Heather Jim
Journal:  Br J Haematol       Date:  2009-11-16       Impact factor: 6.998

10.  The PROMIS Physical Function item bank was calibrated to a standardized metric and shown to improve measurement efficiency.

Authors:  Matthias Rose; Jakob B Bjorner; Barbara Gandek; Bonnie Bruce; James F Fries; John E Ware
Journal:  J Clin Epidemiol       Date:  2014-05       Impact factor: 6.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.